Skip to main content

HMSI proposes New Bikes to take on Enfield

 

Honda Motorcycle & Scooter India (HSMI) the countries second largest two-wheeler maker is focusing at introducing a multiple product to take on Royal Enfield in the 250-500 cc or on mid-weight motorcycle segment. HMSI has currently two products namely CB350 and CB350RS and the company is targeting a spike in sales units to 3,00,000 units in the category for the next three years with a new portfolio of the locally produced midsized motorcycles.

Atsushi Ogata, HMSI President told that “Sooner or later we will also have our new line-up, with additional products portfolio. The number of models in mid CC segment will increase year by year and surely sales will go up to 3 lakh units within three years and that is our internal target”.

To expand the reach HMSI which currently has 70 BigWing outlets chain for exclusively retailing and servicing premium bikes will now expand its presence to 300 customer touchpoints in the next three years. The company is now working at putting 100 BigWing outlets in place to cover the top 50 units in operation areas by the end of the ongoing financial year and HSMI aims to accelerate the dealer expansion to cover up the top hundred units in operation area in the next financial year.

According to the Society of Indian Automobile Manufacturers 2,76,365 motorcycles with 250-500 cc engine capacity sold in the first seven months in this financial year in the local market with an increase of 4.2% compared to the year ago period. But overall sales of motorcycles declined to 1% in the same period. Royal market share during April – October 2021 was 88.6%  down by 700 basepoints YOY where as HMSI’s share rose to 6.8% from 0.5%  in the same period.

Labels:

Comments

Post a Comment

Popular posts from this blog

The Asian Paints Price Hike Stroke

This paint business, which was once a stock market favourite, hasn't had a fantastic year. While the Sensex has increased by more than 50%, Asian Paints has only increased by 30%. The Synopsis Asian Paints, the world's largest paint manufacturer, has raised prices by just 3% a year for the past 20 years. That's correct, despite the fact that we've had to cope with out-of-control inflation everywhere, paint costs have never been an issue. The corporation, on the other hand, has finally rolled up its sleeves and is getting down to work. Asian Paints, the industry leader, is raising prices by 7–10 percent starting November 12th. Yes, it's advising everyone to spruce up their homes before Diwali. But, you may wonder, why the abrupt change of heart. Of sure, earnings are important. Sales increased by 32% year over year, from Rs 5,350 crores to almost Rs 7,000 crores, according to the company's latest figures (July-September). However, its net income dropped by 28%, f...
Post a Comment
Read more

Pharm Easy: A Mini Portfolio

  Indian Digital healthcare platform Pharm Easy became the latest startup business in our country and listed in domestic market. Pharm Easy provide health service ranging from tele-communication to radiology test and provide home delivery of medical products.   When we compare the past 3months sales of the company, now the monitary value of sales of the company stood at 30.26 billion Rupees. Pharmacy’s company may consider a private issuance of shares worth up to 12.50 billion rupees. Naspers, a technology-focused investor, as well as organizations connected with global investment group CDPQ and private equity firm TPG, are among the company's investors. The company acquired thyrocare technologies, India's leading diagnostic test provider, in order to diversify its operations. The IPO filing for pharmeasy comes on the same day as Nykaa, an Indian fashion         e-commerce firm, is scheduled to debut on the stock exchange, and Paytm, a finance...
Post a Comment
Read more